Immunohistochemistry Doctors in Turkey — Page 2

Associate Professor Tahsin Ozatli is an oncologist at Istinye Liv University Hospital. He specializes in identifying and treating lung, breast, and gastrointestinal cancers.

• Expert in immunohistochemistry used to identify specific cancer subtypes for targeted treatment
• Previously served as a physician at the Ankara Oncology Clinic in Turkey
• Served in the oncology department at Erzurum Regional Training and Research Hospital
• Completed medical training at Selcuk University Faculty of Medicine
• Achieved the rank of Associate Professor in oncology in 2016

Associate Professor Ayse Irem Yasin is an ESMO board-certified oncologist at Medipol Acibadem District Hospital. She uses immunohistochemistry to identify specific marker proteins in tumors.

• Earned ESMO Board Certification in Paris for meeting high European oncology standards
• Completed a clinical observership in breast cancer at Maggiore della Carita Hospital in Italy
• Trained at world-renowned institutions including Cleveland Clinic and Harvard Medical School
• Specializes in immunohistochemical analysis for cancers of unknown primary origin
• Fellowship trained in medical oncology at Bezmialem Vakif University

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Dr. Serdar Bedii Omay is a hematologist-oncologist who specializes in molecular hematology. He uses immunohistochemistry to precisely diagnose complex blood cancers at Emsey Hospital.

• Earned a Ph.D. from Japan Mie Medical School specializing in molecular hematology
• Published 65 scientific articles in international journals regarding blood disorders
• Professor of Hematology at Karadeniz Technical University – one of Turkey's established medical schools
• Expert in CAR T-cell therapy – a treatment where immune cells are modified to fight cancer
• Presented 112 papers at international medical meetings regarding hematologic malignancies

Dr. Rafet Eren is a hematologist at Biruni University Hospital in Istanbul. He specializes in treating leukemia, lymphoma, and myeloma. Dr. Eren is an Associate Professor with around 50 scientific publications in international journals. He received the Young Researcher Award from the Turkish Society of Hematology.

• Performs bone marrow transplants and haploidentical stem cell transplantation.
• Provides CAR T-cell therapy and biological treatments for blood cancers.
• Member of the European Society of Hematology and the Turkish Hematology Association.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Dr. Senem Karabulut is a medical oncologist at Biruni University Hospital in Istanbul. She is a professor and holds a PhD in molecular oncology. Dr. Karabulut is certified by the European Society for Medical Oncology (ESMO) Board. She previously trained as an observer at University Hospital in New Jersey, USA.

• Specializes in immunotherapy and targeted treatments for gastrointestinal and breast cancers.
• Treats hepatobiliary system tumors, lung cancer, and genitourinary malignancies.
• Qualified by the Turkish Medical Oncology Society Board Exam.
• Practices at Biruni University Hospital, a TEMOS-accredited facility.

Dr. Didem Karacetin is a radiation oncologist at Biruni University Hospital in Istanbul. She completed clinical training at the Princess Margaret Hospital in Toronto. Dr. Karacetin is a former Head of the Department of Radiation Oncology at Health Sciences University. She specializes in intraoperative radiotherapy for breast cancer and brachytherapy for gynecological tumors.

• Holds a Master’s degree in Phytotherapy from Istanbul University.
• Certified in Hydrogel SpaceOAR applications for prostate cancer treatment.
• Treats lung, brain, and gastrointestinal cancers using targeted radiation.
• Practices at Biruni University Hospital, which holds TEMOS and ISO quality certifications.

Dr. Hilmi Apak is a pediatric hematologist-oncologist at Biruni University Hospital in Istanbul. He specializes in bone marrow transplantation, CAR T-cell therapy, and leukemia chemotherapy. Dr. Apak is the current Head of Department at Istanbul University Department of Pediatrics.

• Published over 70 international medical articles on pediatric oncology research.
• Treats complex conditions like lymphoma, neuroblastoma, and Ewing's sarcoma.
• Served as a board member of the Turkish Pediatric Society.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Dr. Elnur Sahibov trained in radiation oncology at Marmara University. He provides specialized cancer diagnostics at Emsey Hospital.

• Completed specialization training in radiation oncology in 2016
• Graduated through the English-language medical program at Marmara University
• Provides expertise in oncology-related diagnostics like immunohistochemistry
• Practices at Emsey Hospital, a private multidisciplinary medical center

Professor Birol Baytan is a pediatric oncology specialist at Emsey Hospital in Istanbul. He uses immunohistochemistry to identify specific markers for pediatric cancers and blood disorders.

• Performed 950 bone marrow transplants for children with complex blood diseases
• Works in one of Turkey's largest pediatric bone marrow transplant units
• Published 15 research articles in international peer-reviewed medical journals
• Authored three books and several chapters on pediatric health and hematology
• Member of the international scientific community presenting at global medical meetings

Dr. Osman Ilhan was part of the team that performed Turkey's first bone marrow stem cell transplant. He focuses on leukemia, Hodgkin lymphoma, and myeloma treatments at Private Koru Ankara Hospital. Dr. Ilhan has authored over 300 PubMed publications with 5,000+ citations. He holds the Platinum CME certificate from the European Hematology Association.

• Helped establish the Turkish Stem Cell Donor Bank (TURKOK).
• Served as a board chairman for bone marrow transplantation at the Ministry of Health.
• Former President of the Turkish Hematology Association.
• Founded the Cellular Therapy and Regenerative Medicine Association.

Dr. Itir Sirinoglu Temiz is a Professor of Hematology at Liv Hospital Vadistanbul. She specializes in lymphoma, leukemia, and multiple myeloma treatment. Dr. Temiz graduated with honors from the Istanbul University Cerrahpaşa Faculty of Medicine. She has extensive experience in stem cell transplantation and therapeutic apheresis.

• Performs allogeneic and haploidentical stem cell transplants.
• Treats complex blood disorders including thrombosis and bone marrow failure.
• Former Head of Internal Medicine at Istanbul Aydın University.
• Provides care at a JCI-accredited facility in Istanbul.

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages advanced cancer programs with expertise in tumor analysis through immunohistochemistry.

• Completed a post-doctoral radiation fellowship at Thomas Jefferson University in the USA
• Former Chairman of Radiation Oncology at Uludag University Medical College
• Specializes in gastrointestinal, breast, and lung cancer diagnostic pathways
• Conducted cancer risk research at the National Cancer Institute in Bethesda
• Managed oncological science programs at Anadolu Medical Center for 13 years